CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM NO PAR
Total 13F shares
5,599,500
Share change
+3,659
Total reported value
$35,003,000
Price per share
$6.23
Number of holders
24
Value change
+$22,804
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q4 2013

As of 31 Dec 2013, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,599,500 shares. The largest 10 holders included Fortress Investment Group LLC, ADAGE CAPITAL PARTNERS GP LLC, Alistair Capital Management, L.L.C., FMR LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GROUP ONE TRADING, L.P., UBS AG, TFS CAPITAL LLC, and Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp. This page lists 24 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.